Carlyle Buys Stake in Chinese Health-Care Firm for $260 Million

(Bloomberg) -- Carlyle Group agreed to invest 1.78 billion yuan ($260 million) to buy a minority stake in Shenzhen Salubris Pharmaceutical Co., bringing its announced investment in health-care comp...